Skip to main content

Table 1 Demographic data of all patients

From: Effects of high-flow nasal cannula in patients with persistent hypercapnia after an acute COPD exacerbation: a prospective pilot study

 

n = 50

Age, yrs

75,7 ± 9,3

Sex (M/F)

16/34

BMI

26 ± 6

FEV1 (% pred)

42,1 ± 17,4

LTOT (n/total)

27/50

History of mechanical ventilation (n/total)

26/50

“Acute” NIV during exacerbation

(n/total)

35/50

Actual Smokers (n/total)

10/50

Ex-Smokers (n/total)

25/50

Charlson Index

6,4 ± 2,0

pH

7.41 ± 0.06

PaCO2 (mmHg)

60 ± 1.4

PaO2/FiO2

200.5 ± 8.7

HCO3- (mmol/L)

35.3 ± 1.03

Respiratory rate (b/min)

22.02 ± 0.6

  1. Data are presented as mean ± SD
  2. NIV Non invasive ventilation, BMI Body Mass Index, FEV1 Forced Expiratory Volume in the 1st second, LTOT Long Term Oxygen Therapy